Did you know?

Genedata can help you find a needle in a haystack. Synthetic antibody libraries can contain more than one trillion different molecule variants. To identify the few promising novel therapeutic candidates is a huge challenge. To meet this challenge, antibody discovery has become increasingly automated. Genedata Biologics supports fully automated high-throughput screens that identify the most promising drug candidates.


DDW looks at AstraZeneca Use of Genedata Screener Compound Synergy Extension

Journal of Biomolecular Screening features Genedata Screener 12


March 9-13, 2015
March 12, 2015
March 17 - 18, 2015
March 17 - 20, 2015